About this trial
The purpose of this study was to investigate the effect of only local radical treatment of liver metastases combined with systematic treatment in the treatment of patients with multiple organ metastases of colorectal cancer, whether it can benefit the prognosis and explore the risk factors related to the prognosis.
Eligibility criteria
Qualifiers
Male or female, 18-80 years of age.
Patients volunteered to join the study and signed informed consent, with good compliance and follow-up.
Primary colorectal tumors can be radically resected or resected and histopathologically diagnosed as colorectal cancer.
Patients with synchronous or metachronous diagnosis of liver metastasis and extrahepatic metastasis by computed tomography (CT) or magnetic resonance imaging (MRI).Extrahepatic metastases are stable and controllable as determined by Multi-disciplinary Treatment (MDT).
Disqualifiers
Patients with only liver metastasis confirmed by CT or MRI.
History of hepatic encephalopathy or liver transplantation.
Evidence of brain metastases.
Pregnant or breast-feeding women.
Trial design
Treatments tested in this trial
- Radical local Surgery
- Systemic therapy
- Interventional therapy
Treatment groups
Sponsors and collaborators
Anhui Provincial Hospital
Lead sponsor
First Affiliated Hospital of Wannan Medical College
Collaborator